PAG
FLNA

Private Advisor Group’s Filana Therapeutics FLNA Stock Holding History

Private Advisor Group’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5,100
Closed -$213K – 1918
2022
Q3 		$213K Buy
+5,100
New +$138K ﹤0.01% 1646
2022
Q2 		– Sell
-5,450
Closed -$202K – 2232
2022
Q1 		$202K Buy
+5,450
New +$231K ﹤0.01% 1890

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Private Advisor Group's FLNA Position: Q4 2022 in Review

Private Advisor Group sold out of Filana Therapeutics (FLNA) in Q4 2022, closing a stake of 5,100 shares — an estimated $213K sold.

Private Advisor Group first reported a position in FLNA in Q1 2022 and held it in 2 quarters. The position peaked at $213K in Q3 2022. 153 funds tracked by Wall St. Rank hold FLNA as of Q4 2022.

  • Private Advisor Group reported no remaining Filana Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Private Advisor Group sold 5,100 Filana Therapeutics shares in Q4 2022, an estimated $213K.
  • Private Advisor Group first reported a position in Filana Therapeutics in Q1 2022 and held it in 2 quarters.
  • Private Advisor Group's Filana Therapeutics position peaked at $213K in Q3 2022.
  • 153 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2022.

Based on Private Advisor Group's 13F filing for Q4 2022, filed 18 Jan 2023.